Back to results
US 2022/0088012 A1Published application
Combination therapy
AssigneeJanssen Sciences Ireland Unlimited Company
InventorsKoenraad Jozef Lodewijk Marcel Andries, Anil Koul, Maria Cristina Villellas Arilla
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel combinations, which are useful in the treatment of tuberculosis.
Claims16
A process for preparing a combination product, the process comprising bringing into association of the following active ingredients:
- (i) PZA, or a pharmaceutically acceptable salt thereof;
- and
- (ii) a cytochrome bc1 inhibitor, or a pharmaceutically acceptable salt thereof.
-16. (canceled)
A process for preparing a combination product, the process comprising:
- co-packaging two separate pharmaceutical formulations, wherein one pharmaceutical formulation comprises PZA, or a pharmaceutically acceptable salt thereof, and wherein a second separate pharmaceutical formulation comprises a cytochrome bc1 inhibitor, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.